Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Metastatic Solid Tumors × Platinum × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 4 Uterine Cervical Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Stomach Neoplasms 1 Ovarian Neoplasms 1 Metastatic Solid Tumors 1 Glioblastoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Platinum 1 Infusions, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡